Skip to main content

Advertisement

Table 3 Clinical and sociodemographic characteristics at treatment initiation for participants assigned to the outcome death and not assigned to death among those lost to follow-up (n = 1132)

From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada

Characteristic Total (n) Not assigned death (%) Assigned death (%) P-value
Participants lost to follow-up 1132 792 (70.0) 340 (30.0)  
Sex     0.787
Female 232 164 (70.7) 68 (29.3)  
Male 900 628 (69.8) 272 (30.2)  
History of IDUa     <0.001
Yes 177 53 (29.9) 124 (70.1)  
No 651 538 (82.6) 113 (17.4)  
Aboriginal ancestryb     <0.001
Yes 30 13 (43.3) 17 (56.7)  
No 487 379 (77.8) 108 (22.2)  
CD4 cell count (cells/μL)     <0.001
<350 912 604 (66.2) 308 (33.8)  
≥350 220 188 (85.5) 32 (14.5)  
  1. IDU injection drug use
  2. an = 828
  3. bn = 517